Skip to Main Content

Author Details

Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
2000
60
33
PMIDPaper TitleJournal TitlePublished Year
37205196A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials.Front Oncol2023
37205196A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials.Front Oncol2023
37541199Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.Cell2023
37541199Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.Cell2023
36301140Preserving the Phosphoproteome of Clinical Biopsies Using a Quick-Freeze Collection Device.Biopreserv Biobank2022
35767427Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.Anal Chem2022
36301140Preserving the Phosphoproteome of Clinical Biopsies Using a Quick-Freeze Collection Device.Biopreserv Biobank2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
35767427Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.Anal Chem2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
34136904Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.Clin Chem2021
33986749ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery.Front Immunol2021
34136904Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.Clin Chem2021
34858420Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens.Front Immunol2021
34671754Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling.Cell Rep Methods2021
35028612Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.Cell Rep Med2021
34645978A highly annotated database of genes associated with platinum resistance in cancer.Oncogene2021
34359745Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition.Cancers (Basel)2021
34858420Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens.Front Immunol2021
35028612Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.Cell Rep Med2021
34645978A highly annotated database of genes associated with platinum resistance in cancer.Oncogene2021
34671754Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling.Cell Rep Methods2021
33986749ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery.Front Immunol2021
34359745Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition.Cancers (Basel)2021
32575471Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection.Cancers (Basel)2020
32575471Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection.Cancers (Basel)2020
30651561Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.Nat Commun2019
30651561Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.Nat Commun2019
31281117Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors.Mol Cell Proteomics2019
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
31281117Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors.Mol Cell Proteomics2019
29605812Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.DNA Repair (Amst)2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
30131370Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.Sci Signal2018
29474155A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage.Radiat Res2018
29605812Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.DNA Repair (Amst)2018
30131370Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.Sci Signal2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
29474155A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage.Radiat Res2018
28278055Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.Cell Cycle2017
28278055Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.Cell Cycle2017
27017623DNA Replication Stress Phosphoproteome Profiles Reveal Novel Functional Phosphorylation Sites on Xrs2 in Saccharomyces cerevisiae.Genetics2016
27251275Proteogenomics connects somatic mutations to signalling in breast cancer.Nature2016
27017623DNA Replication Stress Phosphoproteome Profiles Reveal Novel Functional Phosphorylation Sites on Xrs2 in Saccharomyces cerevisiae.Genetics2016
27094115Commercially available antibodies can be applied in quantitative multiplexed peptide immunoaffinity enrichment targeted mass spectrometry assays.Proteomics2016
26621847Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling.Mol Cell Proteomics2016
26621847Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling.Mol Cell Proteomics2016
27251275Proteogenomics connects somatic mutations to signalling in breast cancer.Nature2016
27094115Commercially available antibodies can be applied in quantitative multiplexed peptide immunoaffinity enrichment targeted mass spectrometry assays.Proteomics2016
  • 1 - 50 of 120

Recommended Authors

Gian Luca Negri
British Columbia Cancer Research Institute
Career Start Year 2013
Number of shared co-authors 5
Edward L Huttlin
Harvard Medical School
Career Start Year 2006
Number of shared co-authors 3
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 2
Eric J Jaehnig
Baylor College of Medicine
Career Start Year 2003
Number of shared co-authors 11
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 5
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 0
Gerard Cagney
Conway Institute of Biomedical and Biomolecular Sciences, University College Dublin
Career Start Year 2000
Number of shared co-authors 3
Jayantha Gunaratne
Institute of Molecular and Cell Biology
Career Start Year 2000
Number of shared co-authors 6
Parag Mallick
Stanford University
Career Start Year 2000
Number of shared co-authors 7
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 3
Tamar Geiger
Tel Aviv University
Career Start Year 2000
Number of shared co-authors 0
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 7
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Braden Boone
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 3
Igor Jurisica
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 1
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 24
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 5
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 10
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 8
Andrew Emili
Boston University School of Medicine, Boston University
Career Start Year 1991
Number of shared co-authors 3
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 11
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 8
John Quackenbush
Harvard T. H. Chan School of Public Health
Career Start Year 1989
Number of shared co-authors 16
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 18
Michael Snyder
Stanford University
Career Start Year 1981
Number of shared co-authors 41
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 16
John R Yates
TheScripps Research Institute
Career Start Year 1960
Number of shared co-authors 12

Collaborators

Amanda G Paulovich
Co-authored papers 29
Jeffrey R Whiteaker
Co-authored papers 24
Jacob J Kennedy
Co-authored papers 17
Lei Zhao
Co-authored papers 16
Pei Wang
Co-authored papers 14
Regine M Schoenherr
Co-authored papers 12
Ping Yan
Co-authored papers 11
Marc Vidal
Blavatnik Institute, Harvard Medical School
Co-authored papers 9
Shrabanti Chowdhury
Co-authored papers 5
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 5
Brian J Druker
Oregon Health & Science University
Co-authored papers 4
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 4
Frederick P Roth
University of Toronto
Co-authored papers 4
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Samantha L Savage
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Amy Carlos
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 4
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 4
Rachel Henson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 4
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers 4
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 4
Nicola Long
Oregon Health and Science University
Co-authored papers 3
Kavitha Venkatesan
Co-authored papers 3
Robert P Searles
Oregon Health & Science University
Co-authored papers 3
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 3
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 3
Haiyuan Yu
Weill Institute for Cell and Molecular Biology, Cornell University
Co-authored papers 3
Release 1.2